[老年患者の腹腔膜欠陥:症例報告]
Kazuhiro Tani1, Katsushi Ueyama, Reo Sakakura
1Department of Cardiovascular Surgery, Kanazawa Cardiovascular Hospital, Kanazawa, Japan.
Kyobu geka. The Japanese journal of thoracic surgery
|August 21, 2025
まとめ
治療されていない大きな心室隔膜欠陥 (VSD) を患った85歳の女性は,独特の解剖学により,何十年にもわたって心不全を患わずに生き延びました. このケースでは 高齢のVSD患者に対する パーソナライズされた手術アプローチが強調されています
科学分野:
- 心臓病科
- 生まれつき の 心臓 病
- 高齢者医療
背景:
- 室隔膜欠陥 (VSD) は一般的な先天性心異常である.
- 高齢に達した未治療のVSDは極めて稀です.
- 遅い発症はしばしば重大な併発症や心不全を伴う.
研究 の 目的:
- 大量の未治療の 静脈損傷を報告する
- この珍しいシナリオにおける 長期的な生存に寄与する要因を探る
- 高齢のVSD患者における手術の意思決定への影響について議論する.
主な方法:
- 呼吸不全の85歳の女性の症例報告
- エコカルジオグラフィーと心臓キャセテリゼーションを含む診断評価
- ダクロンパッチを用いて手術でVSDを閉じる.
主要な成果:
- 患者は大きなVSD (12x16mm) と軽度の肺高血圧を示したが,心不全はなかった.
- 初期に心不全が起こらなかったのは,シャントの流れを制限するトラベキュラ筋が膨張したせいだった.
- 手術によるVSD閉塞の後の術後の回復は良好でした.
結論:
- 特定の解剖学的変異は,大きな,未治療のVSDで長期的な生存を可能にします.
- 漸進的な右心房縮は 遅発の心不全につながる可能性があります
- 年配のVSD患者にとって 個別化された手術戦略は極めて重要です
関連する概念動画
Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
Cardiomyopathy III: Hypertrophic Cardiomyopathy
47
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47
Mitral Regurgitation I: Introduction
55
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22


